Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment

  • End date
    Jun 6, 2025
  • participants needed
  • sponsor
    Institut du Cancer de Montpellier - Val d'Aurelle
Updated on 13 November 2021


The purpose of this this study, to evaluate the quality of sexual life of patients treated for anal cancer treated by radiotherapy, during their treatment, then 3 months after treatment and, finally, 2 years after treatment. cancer diagnosis.


Sexual health is defined by WHO in 2011 as a state of physical, emotional, mental and social well-being in relation to sexuality. It is an integral part of health, well-being and quality of life and is recognized as a right of everyone.Alteration of sexuality after cancer impacts all phases of the sexual response. It is multifactorial: psychological (ie, anxiety linked to the disease, fear of death, or impairment of body image) and physiological (ie, alteration of the sexual reaction which may be linked, in part, to direct sequelae generated by irradiation of the genitals).

Anal cancer remains fairly rare, affecting around 2,200 people each year in France, with a predominance of women (60 to 70% of patients), However, its incidence has been growing strongly for 30 years, in Europe and the United States where it is has increased by 70% over the last 10 years alone, in both men and women, with an increasingly younger population.

It is linked, in more than 90% of cases, to a carcinogenic virus, the Human PapillomaVirus (HPV), a late consequence of an infection, most often asymptomatic, transmitted by the sexual route.

The question of sexuality after cancer remains, in fact, very little addressed by doctors who express a lack of training. Patients, for their part, often do not dare to raise the issue with caregivers, out of modesty, or thinking that the teams do not have the time. Discussions with patients therefore generally always remain focused on oncological management, from the initial consultation to the follow-up consultations. The hope of recovery awaited on each of the assessments and the fear of relapse often obscure more global and equally essential questions: whether it is about the quality of life, the after-effects, or even more, the quality. of sex life. For these reasons, this study will collect the information provided to patients on the impact of this treatment on their sexual health, whether it is medical information recorded in the file, or information perceived and retained by patients.

Condition human papillomavirus vaccine, Sexuality, HPV Infection, Sexual Behavior, HPV, anal carcinoma, human papilloma virus vaccine, Anxiety, ANXIETY NEUROSIS, anxious, Anxiety Symptoms, mental stress, anxiety disorder, Anxiety Disorders, life stress, Anxiety Disorders (Pediatric), Generalized Anxiety Disorder (GAD - Pediatric), hpv vaccine, Human Papillomavirus Infection, psychologic stress, Rectal Cancer, Psychological stress, Generalized Anxiety Disorder (GAD), Anal Cancer
Treatment Quality of Life questionnaire
Clinical Study IdentifierNCT05109468
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle
Last Modified on13 November 2021


Yes No Not Sure

Inclusion Criteria

Age> 18 years old
Patient treated for non-metastatic squamous cell anus cancer with the presence of an HPV infection authenticated on the biopsy
Patient living with a partner or having an active sex life the year preceding the diagnosis
Patient who, after information, agrees to participate in the study
Patient affiliated to a French social security scheme

Exclusion Criteria

Patient unable or unwilling to complete a questionnaire on the quality of sexual life
Patient without sexual activity the year before diagnosis
Patient whose regular follow-up is impossible for psychological, family, social or geographic reasons
Patient under guardianship, curatorship or legal protection
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note